跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
得宝松 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Betamethasone Injection
Approved
化学药品
Compound Betamethasone Injection
MSD Merck Sharp & Dohme AG
🇨🇳 National Medical Products Administration
Approval Date
Sep 17, 2018
Approval ID
7LeagEtAqKn
Company
MSD Merck Sharp & Dohme AG
Type
化学药品
Approval Details
Approval Id
7LeagEtAqKn
Approval Number
国药准字J20140160
Generic Name
复方倍他米松注射液
Generic Name En
Compound Betamethasone Injection
Trade Name
得宝松
Drug Type
化学药品
Dosage Form
注射剂
Strength
1ml:二丙酸倍他米松(以倍他米松计)5mg与倍他米松磷酸钠(以倍他米松计)2mg
Reg Date
2018-09-17
Company Name
MSD Merck Sharp & Dohme AG
Company Address
Werftestrasse 4, 6005 Luzern
Production Company Name
schering-plough labo n.v.
Production Company Address
Industriepark 30 2220, Heist-op-den-Berg
Company Detail Path
/organization/msd-merck-sharp-and-dohme-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 17, 2018
Approval ID
7LeagEtAqKn
Type
化学药品
Back to NMPA Approvals